JNJ - Regeneron J&J receive millions to develop new COVID therapies
2023-08-22 14:52:24 ET
More on Regeneron, Johnson & Johnson
- Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rating Upgrade)
- Johnson & Johnson Vs. Kenvue: The Better Dividend Aristocrat Might Shock You
- ICON: Economic Business Returns Lagging Capital Charge, Revise To Hold
- Compare metrics for ICLR to JNJ, REGN
For further details see:
Regeneron, J&J receive millions to develop new COVID therapies